Mucosal changes, (measured as number, type and localization of small bowel mucosal lesions detected by VCE) from baseline (i.e. < 7 days prior to inclusion), and after 6 and 12 weeks´ treatment with 4g Pentasa Sachet 12 weeks [clinicaltrials_resource:c269dbe2205b2302af7638dec06bf83d]
Pentasa (mesalazine) sachets 2 g morning + 2 g evening during 12 weeks treatment
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Mucosal changes, (measured as number, type and localization of small bowel mucosal lesions detected by VCE) from baseline (i.e. < 7 days prior to inclusion), and after 6 and 12 weeks´ treatment with 4g Pentasa Sachet 12 weeks [clinicaltrials_resource:c269dbe2205b2302af7638dec06bf83d]
Pentasa (mesalazine) sachets 2 g morning + 2 g evening during 12 weeks treatment
Bio2RDF identifier
c269dbe2205b2302af7638dec06bf83d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c269dbe2205b2302af7638dec06bf83d
measure [clinicaltrials_vocabulary:measure]
Mucosal changes, (measured as ...... eatment with 4g Pentasa Sachet
time frame [clinicaltrials_vocabulary:time-frame]
description
Pentasa (mesalazine) sachets 2 g morning + 2 g evening during 12 weeks treatment
identifier
clinicaltrials_resource:c269dbe2205b2302af7638dec06bf83d
title
Mucosal changes, (measured as ...... ith 4g Pentasa Sachet 12 weeks
@en
type
label
Mucosal changes, (measured as ...... 9dbe2205b2302af7638dec06bf83d]
@en